Increase of 20-HETE Synthase after Brain Ischemia in Rats Revealed by PET Study with 11C-Labeled 20-HETE Synthase-Specific Inhibitor

Protective effect of 20-HETE inhibition in a model of oxygen-glucose deprivation in hippocampal slice cultures

(2012) Marija Renic et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Attenuation of neonatal ischemic brain damage using a 20-HETE synthesis inhibitor

(2012) Zeng-Jin Yang et al.   JOURNAL OF NEUROCHEMISTRY

Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation

(2011) Neha Sehgal et al.   BIOCHEMICAL PHARMACOLOGY

The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice

(2010) Toshiyuki Marumo et al.   BRITISH JOURNAL OF PHARMACOLOGY

11C-PK11195 PET for the In Vivo Evaluation of Neuroinflammation in the Rat Brain After Cortical Spreading Depression

(2009) Y. Cui et al.   JOURNAL OF NUCLEAR MEDICINE

A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist

(2009) N. T. Snider et al.   MOLECULAR PHARMACOLOGY

20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells

(2008) Meetha Medhora et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling

(2007) Jennifer Cheng et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY